Differential expression of the ccn3 (nov) proto-oncogene in human prostate cell lines and tissues

Journal of Clinical Pathology - Molecular Pathology

Volumn 54, Issue 4, 2001, Pages 275-280

  Maillard, M ^a   Cadot, B ^b   Ball, R Y ^c   Sethia, K ^c   Edwards, D R ^a   Perbal, B ^b   Tatoud, R ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

CCN; Human NOV; Prostate tumour

Indexed keywords

CONFERENCE PAPER; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; METASTASIS; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; RNA; TUMOR CELLS, CULTURED;

EID: 0034910661     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.54.4.275     Document Type: Conference Paper

References (37)

1. Genetic basis and clonal evolution of human prostate cancer
2. Molecular biology of prostatic intraepithelial neoplasia
3. Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hydridization
4. Aneusomies of chromosomes 8 and Y detected by fluorecence hybridization are prognostic markers for pathological stage C (pT3N0M0) prostate carcinoma
5. Enhanced expression of the c-myc proto-oncogene in high-grade human prostate cancers
6. Expression of the c-myc protoncogene in human prostatic carcinoma and benign prostatic hyperplasia
7. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization
8. Expression of the c-myc proto-oncogene in prostatic tissue
9. Recurrent cytogenetic alterations of prostate carcinoma and amplification of c-myc or epidermal growth factor receptor in subclones of immortalized PNT1 human prostate epithelial cell line
10. Amplification, rearrangement, and elevated expression of c-myc in the human prostatic carcinoma cell line LNCaP
11. Physical mapping of human loci homologous to the chicken nov proto-oncogene
12. Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephrobastomas
13. Contribution of mav-1-induced nephroblastoma to the study of genes involved in human Wilms-tumor development
14. novH: Differential expression in developing kidney and Wilms' tumors
15. The modular architecture of a new family of growth regulators related to connective tissue growth factor
16. How many insulin-like growth factor binding proteins?
17. Connective-tissue growth-factor - A cysteine-rich mitogen secreted by human vascular endothelial cells is related to the Src-induced immediate early gene product CEF-10
18. Expression of Cyr61, a growth factor-inducible immediate-early gene
19. Expression of the Elm1 gene, a novel gene of the CCN (connective tissue growth factor, Cyr61/CEF10, and neuroblastoma overexpressed gene) family, suppresses in vivo tumor growth and metastasis of K-1735 murine melanoma cells
20. CCN proteins are distinct from and should not be considered members of the insulin-like growth factor-binding protein superfamily
21. Cyr61 and Fisp12 are both ECM-associated signaling molecules: Activities, metabolism, and localization during development
22. Human CYR61-mediated enhancement of bFGF-induced DNA synthesis in human umbilical vein endothelial cells
23. Cyr61, product of a growth factor-inducible immediate early gene, is associated with the extracellular matrix and cell surface
24. A novel transforming growth factor β response element controls the expression of the connective tissues growth factor gene
25. Characterization and expression of the human nov protooncogene in Wilms-tumors
26. The C-terminal domain of the regulatory protein NOVH is sufficient to promote interaction with fibulin 1C: A clue for a role of NOVH in cell-adhesion signaling
27. Nuclear localisation of NOVH protein: A potential role for NOV in the regulation of gene expression
28. Structural analysis of the human nov proto-oncogene and expression in Wilm's tumors
29. Regulation of nov by WT1: A potential role for nov in nephrogenesis
30. v-src
31. Immortalization of human adult normal prostatic epithelial cells by liposomes containing large T-SV40 gene
32. Binding properties and distribution of insulin-like growth factor binding protein-related protein 3 (IGFBP-rP3/NovH), an additional member of the IGFBP superfamily
33. Synthesis and characterization of insulin-like growth factor-binding protein (IGFBP)-7
34. Characterization of insulin-like growth factor-binding protein-related protein-1 in prostate cells
35. Human prostate cancer expresses the low affinity insulin-like growth factor binding protein IGFBP-rP1
36. Expression of the extracellular matrix signalling molecule Cyr61 is down-regulated in prostate cancer
37. The CCN family of angiogenic regulators: The integrin connection